Docetaxel Followed by CEF (Cyclophosphamide, Epirubicin and 5-Fluorouracil) Compared to Docetaxel and Capecitabine Followed by CEX (Cyclophosphamide, Epirubicin and Capecitabine) as Adjuvant Treatment for Breast Cancer

PHASE3CompletedINTERVENTIONAL

Enrollment

1,500

Participants

Timeline

Start Date

January 31, 2004

Study Completion Date

April 30, 2007

Conditions

Breast Cancer

Interventions

DRUG

capecitabine

DRUG

docetaxel

Trial Locations (1)

Department of Oncology, Helsinki University Central Hospital, Finland, Helsinki